Pasireotide in Hyperinsulinemic Hypoglycemia

Status Withdrawn

Clinical Trial Summary

This is a small controlled pilot study to assess the effect of subcutaneous pasireotide on preventing hypoglycemia due to hyperinsulinism, including congenital hyperinsulinism and insulinoma.

Clinical Trial Description

Pasireotide is a somatostatin analog with affinity for several somatostatin receptors including those on pancreatic beta cells; when activated these receptors affect the secretion of glucagon and insulin. Pasireotide is also known to decrease glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) secretion. Hyperglycemia is a well-documented adverse effect of pasireotide in its approved indications for treatment of Cushing's disease and acromegaly. In light of this, the investigators hypothesize that pasireotide may be an effective therapy for hypoglycemia due to hyperinsulinism. Therefore a small controlled pilot study to assess the effect of subcutaneous (s.c.) pasireotide on preventing hypoglycemia due to hyperinsulinism over 7 hours of observation in both fasting and fed states is proposed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03053284
Study type	Interventional
Source	Montefiore Medical Center
Contact
Status	Withdrawn
Phase	Phase 2
Start date	April 2017
Completion date	April 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00074451` - Genomewide Search for Loci Underlying Metabolic Syndrome
Completed	`NCT00073775` - Epidemiology of Stress and the Metabolic Syndrome	N/A
Completed	`NCT00005380` - Insulin, Androgen, and Risk in African-American Women	N/A
Completed	`NCT00005709` - Lipoprotein Metabolism in Hypertensive African-Americans	N/A
Recruiting	`NCT05088798` - Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism	Phase 2
Not yet recruiting	`NCT05950282` - Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
Completed	`NCT02248272` - Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes	N/A
Completed	`NCT00937079` - Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients	Phase 1
Completed	`NCT00151684` - Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men	Phase 2
Completed	`NCT00004825` - Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism	N/A
Completed	`NCT00005530` - Diet, Insulin Resistance, and Cardiovascular Risk	N/A
Recruiting	`NCT05662189` - Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus	N/A
Recruiting	`NCT04744896` - Effects Of Combined Cryolipolysis And High Intensity Interval Training On Insulin Resistance And Body Composition In Polycystic Ovarian Patients	N/A
Completed	`NCT05329337` - Link Between the Peripheral Mononuclear Cells' Capacity to Induce Insulin Resistance and Hyperinsulinemia	N/A
Not yet recruiting	`NCT05989347` - Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy	Phase 1
Recruiting	`NCT05543083` - Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes	N/A
Recruiting	`NCT05774613` - Effect of Hibiscus Sabdariffa Beverage	N/A
Recruiting	`NCT06363929` - Continuous Glucose Monitoring in Neonatal Hyperinsulinism
Completed	`NCT03358745` - Impact of Meal Order on Postprandial Cardiometabolic Risk Markers	N/A
Not yet recruiting	`NCT05764200` - Acute Microbial Switch	N/A